Financial results - PHARMASENSE CONSULTANCY S.R.L.

Financial Summary - Pharmasense Consultancy S.r.l.
Unique identification code: 40907921
Registration number: J16/1145/2019
Nace: 7490
Sales - Ron
35.516
Net Profit - Ron
29.650
Employees
Open Account
Company Pharmasense Consultancy S.r.l. with Fiscal Code 40907921 recorded a turnover of 2024 of 35.516, with a net profit of 29.650 and having an average number of employees of - . The company operates in the field of Alte activitati profesionale, stiintifice si tehnice n.c.a. having the NACE code 7490.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Pharmasense Consultancy S.r.l.

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR - - - - 24.059 43.634 37.195 27.728 34.486 35.516
Total Income - EUR - - - - 24.059 43.984 37.663 27.823 34.619 35.516
Total Expenses - EUR - - - - 122 82 541 231 532 218
Gross Profit/Loss - EUR - - - - 23.937 43.903 37.122 27.592 34.087 35.298
Net Profit/Loss - EUR - - - - 23.215 42.586 36.006 26.761 28.633 29.650
Employees - - - - 0 0 0 0 0 0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 3.6%, from 34.486 euro in the year 2023, to 35.516 euro in 2024. The Net Profit increased by 1.177 euro, from 28.633 euro in 2023, to 29.650 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Pharmasense Consultancy S.r.l.

Rating financiar

Financial Rating -
PHARMASENSE CONSULTANCY S.R.L.

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Pharmasense Consultancy S.r.l.

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Pharmasense Consultancy S.r.l.

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Pharmasense Consultancy S.r.l.

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Pharmasense Consultancy S.r.l. - CUI 40907921

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets - - - - 0 0 0 0 0 0
Current Assets - - - - 13.675 34.922 29.475 20.172 33.474 36.366
Inventories - - - - 0 0 0 0 0 0
Receivables - - - - 6.741 9.572 8.743 14.646 21.877 32.530
Cash - - - - 6.934 25.350 20.733 5.526 11.597 3.835
Shareholders Funds - - - - 9.737 31.537 25.203 14.034 31.366 30.004
Social Capital - - - - 42 41 40 41 40 40
Debts - - - - 3.938 3.385 4.273 6.138 2.107 6.814
Income in Advance - - - - 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "7490 - 7490"
CAEN Financial Year 7490
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 36.366 euro in 2024 which includes Inventories of 0 euro, Receivables of 32.530 euro and cash availability of 3.835 euro.
The company's Equity was valued at 30.004 euro, while total Liabilities amounted to 6.814 euro. Equity decreased by -1.188 euro, from 31.366 euro in 2023, to 30.004 in 2024.

Risk Reports Prices

Reviews - Pharmasense Consultancy S.r.l.

Comments - Pharmasense Consultancy S.r.l.

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.